@article {Ferrarajrheum.171200, author = {Giovanna Ferrara and Serena Pastore and Lara Sancin and Lucio Torelli and Oriano Radillo and Matteo Bramuzzo and Chiara Bibalo and Alberto Tommasini and Alessandro Ventura and Andrea Taddio}, title = {Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis}, elocation-id = {jrheum.171200}, year = {2018}, doi = {10.3899/jrheum.171200}, publisher = {The Journal of Rheumatology}, abstract = {Objective This study aimed to test fecal calprotectin (FC) as a screening tool to identify inflammatory bowel disease (IBD) among patients with juvenile idiopathic arthritis (JIA). Methods FC level \< 100 g/kg was considered normal. Patients with 2 consecutive FC dosage >= 100 g/kg underwent endoscopic evaluation. Results There were 113 patients with JIA enrolled. FC was raised in 7 patients out of 113. All patients had IBD. In 3/7 patients, high FC levels were the only sign consistent with IBD. Conclusion FC is a useful, economical, and noninvasive diagnostic tool to identify JIA patients with underlying IBD.}, issn = {0315-162X}, URL = {https://www.jrheum.org/content/early/2018/06/11/jrheum.171200}, eprint = {https://www.jrheum.org/content/early/2018/06/11/jrheum.171200.full.pdf}, journal = {The Journal of Rheumatology} }